Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway

Inflammatory bowel disease (IBD), characterized by sustained inflammation, is a latent risk factor of colon tumorigenesis. Silibinin has been reported to be anti-inflammatory and antineoplastic, but its efficacy on colitis-associated cancer (CAC) has not been reported. Interlukin-6/signal transducer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Rongjuan, Ma, Jiaheng, Wang, Dan, Dong, Wenxiao, Wang, Sinan, Liu, Tianyu, Xie, Runxiang, Liu, Li, Wang, Bangmao, Cao, Hailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222218/
https://www.ncbi.nlm.nih.gov/pubmed/30498394
http://dx.doi.org/10.1155/2018/1562010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222218/
https://www.ncbi.nlm.nih.gov/pubmed/30498394
http://dx.doi.org/10.1155/2018/1562010

Ejemplares similares